FAM126A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.999600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.019830E-01
Normal-vs-Stage2
7.607700E-02
Normal-vs-Stage3
9.979800E-02
Normal-vs-Stage4
4.638200E-01
Stage1-vs-Stage2
4.911200E-01
Stage1-vs-Stage3
6.979200E-01
Stage1-vs-Stage4
2.581600E-01
Stage2-vs-Stage3
3.709400E-01
Stage2-vs-Stage4
4.916800E-01
Stage3-vs-Stage4
1.550990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.358300E-02
Normal-vs-AfricanAmerican
4.727600E-01
Normal-vs-Asian
3.991900E-02
Caucasian-vs-AfricanAmerican
3.497400E-01
Caucasian-vs-Asian
5.122000E-01
AfricanAmerican-vs-Asian
2.120200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.868400E-02
Normal-vs-Female
1.397170E-01
Male-vs-Female
2.831000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.199800E-01
Normal-vs-Age(41-60Yrs)
3.055000E-01
Normal-vs-Age(61-80Yrs)
2.501900E-02
Normal-vs-Age(81-100Yrs)
2.637400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.181200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.207200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.451000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.006300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.495770E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.415200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.555600E-02
Normal-vs-Daily Drinker
1.876370E-01
Normal-vs-Weekly Drinker
5.493000E-01
Normal-vs-Occasional Drinker
2.028800E-01
Normal-vs-Social Drinker
2.683800E-01
Non Drinker-vs-Daily Drinker
2.166300E-02
Non Drinker-vs-Weekly Drinker
3.524800E-01
Non Drinker-vs-Occasional Drinker
3.543000E-01
Non Drinker-vs-Social Drinker
2.808400E-01
Daily Drinker-vs-Weekly Drinker
8.237800E-02
Daily Drinker-vs-Occasional Drinker
1.747820E-02
Daily Drinker-vs-Social Drinker
2.412100E-02
Weekly Drinker-vs-Occasional Drinker
6.824600E-01
Weekly Drinker-vs-Social Drinker
7.750600E-01
Occasional Drinker-vs-Social Drinker
8.642600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.427600E-01
Normal-vs-Grade 2
6.301400E-01
Normal-vs-Grade 3
6.281000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.650400E-01
Grade 1-vs-Grade 3
5.500000E-01
Grade 1-vs-Grade 4
6.427600E-01
Grade 2-vs-Grade 3
9.005600E-01
Grade 2-vs-Grade 4
6.301400E-01
Grade 3-vs-Grade 4
6.281000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.552200E-02
Normal-vs-NonDiabetic
7.470000E-02
Diabetic-vs-NonDiabetic
9.753200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.273600E-01
Normal-vs-NoPancreatitis
8.819800E-02
Pancreatitis-vs-NoPancreatitis
5.258400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.986400E-02
Normal-vs-N1
8.752500E-02
N0-vs-N1
6.834000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.012000E-02
Normal-vs-TP53-NonMutant
1.181590E-01
TP53-Mutant-vs-TP53-NonMutant
2.562200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
